ACET
ACET
NASDAQ · Biotechnology

Adicet Bio Inc

$7.03
+0.59 (+9.16%)
As of Feb 8, 2:16 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +106.8% upside
Low Target $12.76
Average Target $14.54
High Target $24.66
Current Price $7.03
Current
$7.03
Target
$14.54
$12.76 $14.54 avg $24.66
Scenario Analysis
Bear Case
$12.76
81.5%
Low target
Base Case
$14.54
+106.8%
Avg target
Bull Case
$24.66
+250.8%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$20.69
-66.0% from high
52-Week Low
$7.45
+-5.6% from low
Target vs 52W High
$14.54
-29.7% vs high
Next Earnings Report
Mar 4, 2026 · After Market Close
16d
until earnings
EPS Est: $-2.86
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%